Gliclazide -DRP-4138

Main information

  • Trade name:
  • Gliclazide -DRP-4138 30 mg Modified-Release Tablet
  • Dosage:
  • 30 mg
  • Pharmaceutical form:
  • Modified-Release Tablet
  • Units in package:
  • Alu/Alu Blister Pack x 10's (box of 30's and 60's)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Lek Pharmaceuticals d.d

Documents

Localization

  • Available in:
  • Gliclazide -DRP-4138 30 mg Modified-Release Tablet
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-4138
  • Authorization date:
  • 13-12-2022
  • Last update:
  • 06-04-2018